Mark Hazeltine - Chief Business Officer at EXAGEN INC.

Insider Transactions and Holdings

Identity
Entity type
Individual
Issuer context
SEC evidence

There are no Buy or Sell transactions made by Mark Hazeltine since 31 May 2025

Holdings reported by Mark Hazeltine for EXAGEN INC.

Form 4 holding Chief Business Officer

EXAGEN INC.

Security class
Common Stock
Shares / value
190,205
Estimated value
$331,927
Report date
02 Mar 2023
Price
$1.75
Ownership
Direct

Transactions reported by Mark Hazeltine for EXAGEN INC.

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .